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Effect of Volume Loading on Left Atrial Appendage Closure*Sameer Gafoor, MD,yz Mayank Agrawal, MD,y Horst Sievert, MD, PHDzI n this issue of JACC: Cardiovascular Interven-tions, Spencer et al. (1) from the Vancouver Gen-eral Hospital group discuss an important topic in
left atrial appendage (LAA) closure. Sizing, as in
transcatheter aortic valve replacement (TAVR) and
other structural heart interventions, is of the utmost
importance in LAA closure. This is one of the ﬁrst pa-
pers asking us to ﬁgure out whether what we are
measuring is correct.SEE PAGE 1935In TAVR, much has been made of the noncircular
nature of the aortic annulus as well as changes during
systole and diastole. The same has not (yet) been
mandated for left atrial appendage measurements;
the measurement of the ostium is often the largest
measurement on transesophageal echocardiography
in 4 views (usually 0, 45, 90, and 135). This is very
important because the left atrial appendage is a very
variable structure, with 1 or multiple lobes that arise
at various angles. The appendage ostium diameter
and length help to deﬁne device selection as well as
device size.*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
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if that diameter is incorrect? Patients are fasting
before their procedure, often decreasing intravas-
cular volume. The left atrial appendage responds to
volume loading, which can lead a 10% size increase in
the left atrial appendage. As the group illustrates, this
can lead to 1 size difference for the Watchman device
(Boston Scientiﬁc Inc., Marlborough, Massachusetts).
Unlike the TAVR annulus, which is often covered with
calcium, the left atrial appendage ostium is depen-
dent on the ﬂuid status.
This could be the reason why small leaks occur. One
can see how a device could be implanted with perfect
procedural success. However, measurements were
made under fasting conditions; when the patient is
back at home and well hydrated, then the appendage
is at its full size and the device membrane may no
longer have contact with the wall. In addition, this
could help to explain the ﬁndings by Meincke et al.
(2), who instead of the 8% to 20% oversizing did a
15% to 30% oversizing at implantation and found
less leakage and device repositioning; perhaps the
results can be explained by underexpansion of the
LAA. Although not published, the same could also
be considered for the Amplatzer Cardiac Plug and
Amulet devices (St. Jude Medical, St. Paul, Minnesota)
as well as epicardial closure devices.
It is interesting to wonder what happens to the
depth of the left atrial appendage with volume
loading. As the ostium “grows,” the trabeculated distal
tissue may expand a bit as well. This raises certain
questions because certain devices (Watchman) require
signiﬁcant depth of appendage for a satisfactory
and safe implantation. Even if the depth of the
appendage grows by 10%, this still is often not enough
to allow a Watchman in the cases in which the depth is
a concern.
Giving intravenous ﬂuids during a case may spark
some issues. Patients with low ejection fraction may
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1943not handle the ﬂuid easily, with a risk of pulmonary
edema (the investigators decreased the bolus to
500 ml in these cases and did not have any of these
effects). The investigators gave the ﬂuids during
traditional procedural steps, but it is an additional task
that one must remember. The “cutoff” of 12 mm Hg is
arbitrary; there is no description of what to do if the
pressure remains <12 mm Hg after volume adminis-
tration (not sure if this happened but the number is
small in this study). However, these challenges are
surmountable; the patient can have ﬂuids given before
procedure. In addition, the ﬂuids may also make it
easier to perform a safe transseptal puncture.
The investigators describe the lack of a comparator
group as a limitation of this study, as this would really
show the beneﬁt of volume loading on device selec-
tion as well as the prevalence of a peridevice leak.
However, we do not need a comparator group to beconvinced of the need for this step. At the Cardio-
Vascular Center Frankfurt, our practice is to check left
atrial pressure immediately after transseptal punc-
ture; ﬂuids are given if the pressure is <10 mm Hg.
This is one of the key points mentioned during the
CSI LAA courses and live cases over the past few
years. The work by Spencer et al. (1) adds more data to
support the practice of volume loading.
Judicious intravenous ﬂuid loading should be part
of the procedural steps for left atrial appendage
closure. We can say here that the patient who is NPO
(nil per os) is at risk of NPOM (not precise ostial
measurements).
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